Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches

Yani Zhang; Guanghao Zhu; Wei Liu; Yuan Xiong; Qing Hu; Xiaoyu Zhuang; Guihua Jia; Weidong Zhang; Guang‐Bo Ge

doi:10.1016/j.phymed.2023.154796

Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches

Yani Zhang(Shanghai University of Traditional Chinese Medicine), Guanghao Zhu(Shanghai University of Traditional Chinese Medicine), Wei Liu(Shanghai University of Traditional Chinese Medicine), Yuan Xiong(Shanghai University of Traditional Chinese Medicine), Qing Hu(Shanghai University of Traditional Chinese Medicine), Xiaoyu Zhuang(Shanghai University of Traditional Chinese Medicine), Guihua Jia(Shanghai University of Traditional Chinese Medicine), Weidong Zhang(Shanghai University of Traditional Chinese Medicine), Guang‐Bo Ge(Shanghai University of Traditional Chinese Medicine)

Phytomedicine

March 29, 2023

10.1016/j.phymed.2023.154796

Cited by 19Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis